not losing belly fat on tirzepatide 10 Reasons You Are Weight GLP-1s What to Expect from Tirzepatide

Phase 2 Results in Type 2 Diabetes A separate Phase 2 study examined retatrutide in adults with type 2 diabetes and obesity

Individuals with underlying gastrointestinal conditions may experience more pronounced symptoms and should consult healthcare providers before initiating supplementation

The semaglutide vs tirzepatide comparison shows tirzepatide consistently outperforming semaglutide in head-to-head trials for weight loss, regardless of administration route

In short: GLP-1/GIP therapies improve body composition , helping you lose fat while maintaining and often improving your lean-mass ratio and muscle function

The medication is gradually increased over several weeks, starting at 0.25 mg weekly for the first four weeks, then typically increasing to 0.5 mg, with potential further titration to 1 mg or 2 mg depending on glycaemic control and tolerability

This applies to both injectable and oral GLP-1 formulations